Contents

• COMMITTEE TO STUDY NEW RESEARCH ON VACCINES
• INTRODUCTION AND BACKGROUND
• CASE REPORTS AND PASSIVE SURVEILLANCE
  • Introduction
  • Discussion
• LARGE-LINKED DATABASES
  • Introduction
  • Discussion
• CLINICAL TRIALS
  • Introduction
  • Discussion
• OTHER TOPICS
  • Unvaccinated Controls
  • Background Incidence Rates
  • Adverse Events with Long Latencies
  • Multifactorial Etiologies
  • Need for Basic Research
• SUMMARY
• REFERENCES
• Acronyms
• Workshop on Research Strategies for Assessing Adverse Events Associated with Vaccines

The project was supported by funds coordinated through the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (contract no. NO1-AI-15130).

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

This report has been reviewed by a group other than the authors according to procedures approved by a Report Review Committee consisting of members of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

The Institute of Medicine was chartered in 1970 by the National Academy of Sciences to enlist distinguished members of the appropriate professions in the examination of policy matters pertaining to the health of the public. In this the Institute acts under the Academy's 1863 congressional charter responsibility to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine.